LINEAGE CELL THERAPEUTICS IN

Ticker: LCTX CUSIP: 53566P109 Class: COM

Long Focus Capital Management, LLC's Holding History (CIK: 0001602716)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 215,000 Value ($000) $195 Avg Close $0.93 Range $0.77 - $1.15
Q2 2024
Shares 215,000 Value ($000) $214 Avg Close $1.10 Range $0.84 - $1.56
Q1 2024
Shares 215,000 Value ($000) $318 Avg Close $1.13 Range $0.84 - $1.61
Q4 2023
Shares 215,000 Value ($000) $234 Avg Close $1.10 Range $0.90 - $1.37
Q3 2023
Shares 215,000 Value ($000) $254 Avg Close $1.36 Range $1.15 - $1.54
Q2 2023
Shares 215,000 Value ($000) $303 Avg Close $1.38 Range $1.24 - $1.57
Q1 2023
Shares 215,000 Value ($000) $323 Avg Close $1.40 Range $1.16 - $1.58
Q4 2022
Shares 215,000 Value ($000) $252 Avg Close $1.26 Range $1.02 - $1.51
Q3 2022
Shares 215,000 Value ($000) $243 Avg Close $1.47 Range $1.11 - $1.79
Q2 2022
Shares 215,000 Value ($000) $340 Avg Close $1.32 Range $1.10 - $1.64
Q1 2022
Shares 215,000 Value ($000) $331 Avg Close $1.55 Range $1.18 - $2.58
Q4 2021
Shares 215,000 Value ($000) $527 Avg Close $2.34 Range $1.80 - $2.71